165 related articles for article (PubMed ID: 31028894)
21. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C; Wu EQ; Ray S; Colice GL
Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
[TBL] [Abstract][Full Text] [Related]
22. COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada.
Ismaila AS; Risebrough N; Li C; Corriveau D; Hawkins N; FitzGerald JM; Su Z
Respir Med; 2014 Sep; 108(9):1292-302. PubMed ID: 25175480
[TBL] [Abstract][Full Text] [Related]
23. Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma.
Ind PW; Dal Negro R; Colman NC; Fletcher CP; Browning D; James MH
Respir Med; 2003 May; 97(5):555-62. PubMed ID: 12735675
[TBL] [Abstract][Full Text] [Related]
24. The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma.
Malone R; LaForce C; Nimmagadda S; Schoaf L; House K; Ellsworth A; Dorinsky P
Ann Allergy Asthma Immunol; 2005 Jul; 95(1):66-71. PubMed ID: 16095144
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
26. Inhaled salmeterol/fluticasone propionate: a review of its use in asthma.
Reynolds NA; Lyseng-Williamson KA; Wiseman LR
Drugs; 2005; 65(12):1715-34. PubMed ID: 16060707
[TBL] [Abstract][Full Text] [Related]
27. Fluticasone versus salmeterol/low-dose fluticasone for long-term asthma control.
Heyneman CA; Crafts R; Holland J; Arnold AD
Ann Pharmacother; 2002 Dec; 36(12):1944-9. PubMed ID: 12452759
[TBL] [Abstract][Full Text] [Related]
28. Improvement in asthma endpoints when aiming for total control: salmeterol/fluticasone propionate versus fluticasone propionate alone.
Woodcock AA; Bagdonas A; Boonsawat W; Gibbs MR; Bousquet J; Bateman ED;
Prim Care Respir J; 2007 Jun; 16(3):155-61. PubMed ID: 17551661
[TBL] [Abstract][Full Text] [Related]
29. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group.
Condemi JJ; Goldstein S; Kalberg C; Yancey S; Emmett A; Rickard K
Ann Allergy Asthma Immunol; 1999 Apr; 82(4):383-9. PubMed ID: 10227337
[TBL] [Abstract][Full Text] [Related]
30. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
van Noord JA; Schreurs AJ; Mol SJ; Mulder PG
Thorax; 1999 Mar; 54(3):207-12. PubMed ID: 10325895
[TBL] [Abstract][Full Text] [Related]
31. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
Chapman KR; Ringdal N; Backer V; Palmqvist M; Saarelainen S; Briggs M
Can Respir J; 1999; 6(1):45-51. PubMed ID: 10202220
[TBL] [Abstract][Full Text] [Related]
32. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma.
Boulet LP; Franssen E
Respir Med; 2007 Nov; 101(11):2240-7. PubMed ID: 17686624
[TBL] [Abstract][Full Text] [Related]
33. Step-Up Therapy in Black Children and Adults with Poorly Controlled Asthma.
Wechsler ME; Szefler SJ; Ortega VE; Pongracic JA; Chinchilli V; Lima JJ; Krishnan JA; Kunselman SJ; Mauger D; Bleecker ER; Bacharier LB; Beigelman A; Benson M; Blake KV; Cabana MD; Cardet JC; Castro M; Chmiel JF; Covar R; Denlinger L; DiMango E; Fitzpatrick AM; Gentile D; Grossman N; Holguin F; Jackson DJ; Kumar H; Kraft M; LaForce CF; Lang J; Lazarus SC; Lemanske RF; Long D; Lugogo N; Martinez F; Meyers DA; Moore WC; Moy J; Naureckas E; Olin JT; Peters SP; Phipatanakul W; Que L; Raissy H; Robison RG; Ross K; Sheehan W; Smith LJ; Solway J; Sorkness CA; Sullivan-Vedder L; Wenzel S; White S; Israel E;
N Engl J Med; 2019 Sep; 381(13):1227-1239. PubMed ID: 31553835
[TBL] [Abstract][Full Text] [Related]
34. Salmeterol/fluticasone propionate combination.
Spencer CM; Jarvis B
Drugs; 1999 Jun; 57(6):933-40; discussion 941-3. PubMed ID: 10400406
[TBL] [Abstract][Full Text] [Related]
35. Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice daily.
Busse W; Koenig SM; Oppenheimer J; Sahn SA; Yancey SW; Reilly D; Edwards LD; Dorinsky PM
J Allergy Clin Immunol; 2003 Jan; 111(1):57-65. PubMed ID: 12532097
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of fluticasone propionate/salmeterol and fluticasone propionate monotherapy in step-up treatment of childhood asthma: A systematic review and meta-analysis.
Li H; Dong T; Luan J
Heart Lung; 2024; 63():23-34. PubMed ID: 37740997
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.
Nelson HS; Wolfe JD; Gross G; Greos LS; Baitinger L; Scott C; Dorinsky P
Ann Allergy Asthma Immunol; 2003 Sep; 91(3):263-9. PubMed ID: 14533658
[TBL] [Abstract][Full Text] [Related]
38. Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life.
Edin HM; Andersen LB; Schoaf L; Scott-Wilson CA; Ho SY; Ortega HG
Ann Allergy Asthma Immunol; 2009 Apr; 102(4):323-7. PubMed ID: 19441604
[TBL] [Abstract][Full Text] [Related]
39. Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils.
Koopmans JG; Lutter R; Jansen HM; van der Zee JS
J Allergy Clin Immunol; 2005 Nov; 116(5):1007-13. PubMed ID: 16275368
[TBL] [Abstract][Full Text] [Related]
40. Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL study.
Pedersen SE; Bateman ED; Bousquet J; Busse WW; Yoxall S; Clark TJ;
J Allergy Clin Immunol; 2007 Nov; 120(5):1036-42. PubMed ID: 17935765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
